Barry Krakow, MD

Dr. Krakow is a board-certified sleep medicine specialist practicing in Savannah, GA following a 30-year research career that helped spearhead the movement to address sleep disorders in psychiatric patients. Dr. Krakow has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Giovanni Fava, MD

Clinical Professor of Psychiatry at the State University of New York at Buffalo. Editor-in-Chief of the journal Psychotherapy and Psychosomatics and author of over 500 scientific papers. His book, Discontinuing Antidepressant Medications, is due from Oxford University Press in 2021. Dr. Fava has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Michael Linden, MD, PhD
Professor of psychiatry and director of psychosomatic research at the Charité University Medicine Berlin, Germany. Dr. Linden has dual training as a psychologist and psychiatrist and is licensed as a cognitive behavior therapist. He has helped develop new branches of CBT, and his research has brought recognition to the potential side effects of psychotherapy. Dr. Linden has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Donna Sudak, MD

Professor and Vice Chair for Education and Drexel University College of Medicine. She is the author of four books on psychotherapy, including Combining CBT and Medication: An Evidence-Based Approach (Wiley, 2011). Dr. Sudak has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Lois Choi-Kain, MEd, MD
Director of the Gunderson Personality Disorders Institute at McLean Hospital, Belmont, MA. Co-editor of Applications of Good Psychiatric Management for Borderline Personality Disorders: A Practical Guide (APA, 2019) with the late John Gunderson, MD (1942–2019). Dr. Choi-Kain has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.